Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation

Completed

• Conditions: Atrial Fibrillation; Stroke; Aortic Stenosis; Transient Ischemic Attack; Bleeding

• Registration Number: NCT02626871
• Lead Sponsor: University of Turku

Brief Summary

The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-01
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Study First Submitted: 2015-12-08
• Study First Submitted QC: 2015-12-08
• Study First Posted: 2015-12-10
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-01
• Last Update Posted: 2017-05-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 850

Inclusion Criteria

• patients undergoing aortic valve bioprosthesis implantation

Exclusion Criteria

• mechanical heart valves in any position

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	10 years
atrial fibrillation	10 years
major bleeding	10 years
Stroke	10 years

Trial Locations

Locations (1)

Turku University Hospital; 🇫🇮 Turku, Finland